Redhill Biopharma Ltd - Asset Resilience Ratio

Latest as of September 2025: 10.35%

Redhill Biopharma Ltd (RDHL) has an Asset Resilience Ratio of 10.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Redhill Biopharma Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$2.62 Million

Cash + Short-term Investments

Total Assets

$25.34 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Redhill Biopharma Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Redhill Biopharma Ltd (RDHL) total assets.

Liquid Assets Composition Over Time

This chart breaks down Redhill Biopharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Redhill Biopharma Ltd (RDHL) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.62 Million	10.35%
Total Liquid Assets	$2.62 Million	10.35%

Asset Resilience Insights

Moderate Liquidity: Redhill Biopharma Ltd has 10.35% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Redhill Biopharma Ltd Industry Peers by Asset Resilience Ratio

Compare Redhill Biopharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Redhill Biopharma Ltd (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Redhill Biopharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.16%	$2.73 Million	$18.04 Million	+11.73pp
2023-12-31	3.43%	$790.04K	$23.05 Million	+3.42pp
2022-12-31	0.01%	$15.00K	$158.87 Million	-4.70pp
2021-12-31	4.71%	$8.53 Million	$181.19 Million	+4.43pp
2020-12-31	0.28%	$498.00K	$180.24 Million	-25.16pp
2019-12-31	25.44%	$18.85 Million	$74.10 Million	-13.31pp
2018-12-31	38.74%	$24.18 Million	$62.41 Million	-13.14pp
2017-12-31	51.88%	$29.75 Million	$57.34 Million	+35.22pp
2016-12-31	16.67%	$12.37 Million	$74.21 Million	-38.13pp
2015-12-31	54.80%	$36.62 Million	$66.83 Million	-4.30pp
2014-12-31	59.10%	$17.05 Million	$28.86 Million	+57.27pp
2013-12-31	1.83%	$262.00K	$14.34 Million	-5.89pp
2012-12-31	7.72%	$1.55 Million	$20.10 Million	-14.96pp
2011-12-31	22.67%	$4.58 Million	$20.19 Million	+22.53pp
2010-12-31	0.14%	$15.00K	$10.51 Million	--

pp = percentage points

About Redhill Biopharma Ltd

NASDAQ:RDHL USA Drug Manufacturers - Specialty & Generic

Market Cap

$3.60 Million

Market Cap Rank

#29271 Global

#5979 in USA

Share Price

$0.59

Change (1 day)

+7.78%

52-Week Range

$0.55 - $2.52

All Time High

$16290.00